![]() |
|
|
WJ Wu, RM Wolcott and SB Pruett
Department of Biological Sciences, Mississippi State University, Mississippi.
The effects of acute administration of ethanol (EtOH) on natural killer (NK) cells have not previously been examined in mice or humans. In the present study, a single dose of EtOH (5.0-7.0 g/kg) was administered by gavage to B6C3F1 mice. This produced maximum blood EtOH levels of approximately 0.25 to 0.50% (wt/vol). A single dose of EtOH decreased splenic NK cell activity (as measured by lysis of YAC-1 target cells in vitro). This decrease was maximal 12 hr after dosing and was no longer evident at 60 hr. Suppression of NK cell activity was consistently significant at EtOH doses of 6.0 or 6.5 g/kg, and significant suppression occurred in two of three experiments at doses of 5.0 or 5.5 g/kg. Flow cytometric analysis indicated a decrease in the percentage of NK cells in the spleen in EtOH-treated mice, and there was a small decrease in the total number of splenocytes. However, the decrease in the percentage of NK cells was significantly less than the decrease in NK cell activity, suggesting an effect on NK cell activity as well as NK cell number. Splenic T cells were not depleted, but B cells were significantly decreased at the highest EtOH dose. Enhancement of NK activity after in vivo administration of polyinosinic-polycytidilic acid was blocked by EtOH (6.0 g/kg). These results indicate acute exposure to EtOH decreases basal and induced splenic NK cell activity in mice and that loss of NK cells at least partially explains the decrease in basal NK cell activity.
This article has been cited by other articles:
![]() |
J.-S. KIM and S. D. SHUKLA ACUTE IN VIVO EFFECT OF ETHANOL (BINGE DRINKING) ON HISTONE H3 MODIFICATIONS IN RAT TISSUES Alcohol Alcohol., March 1, 2006; 41(2): 126 - 132. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. I. Boyadjieva, K. Chaturvedi, M. M. Poplawski, and D. K. Sarkar Opioid Antagonist Naltrexone Disrupts Feedback Interaction between {micro} and {delta} Opioid Receptors in Splenocytes to Prevent Alcohol Inhibition of NK Cell Function J. Immunol., July 1, 2004; 173(1): 42 - 49. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Poschl and H. K. Seitz ALCOHOL AND CANCER Alcohol Alcohol., May 1, 2004; 39(3): 155 - 165. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Pruett, R. Fan, Q. Zheng, L. P. Myers, and P. Hebert Modeling and Predicting Immunological Effects of Chemical Stressors: Characterization of a Quantitative Biomarker for Immunological Changes Caused by Atrazine and Ethanol Toxicol. Sci., October 1, 2003; 75(2): 343 - 354. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhou and G. G. Meadows Alcohol Consumption Decreases IL-2-Induced NF-{kappa}B Activity in Enriched NK Cells from C57BL/6 Mice Toxicol. Sci., May 1, 2003; 73(1): 72 - 79. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Stickel, D Schuppan, E G Hahn, and H K Seitz Cocarcinogenic effects of alcohol in hepatocarcinogenesis Gut, July 1, 2002; 51(1): 132 - 139. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Boyadjieva, M. Dokur, J. P. Advis, G. G. Meadows, and D. K. Sarkar Chronic Ethanol Inhibits NK Cell Cytolytic Activity: Role of Opioid Peptide {beta}-Endorphin J. Immunol., November 15, 2001; 167(10): 5645 - 5652. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Keil, R. W. Luebke, and S. B. Pruett Quantifying the Relationship Between Multiple Immunological Parameters and Host Resistance: Probing the Limits of Reductionism J. Immunol., October 15, 2001; 167(8): 4543 - 4552. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Pruett, R. Fan, Q. Zheng, L. P. Myers, and P. Hebert Modeling and Predicting Selected Immunological Effects of a Chemical Stressor (3,4-Dichloropropionanilide) Using the Area under the Corticosterone Concentration versus Time Curve Toxicol. Sci., November 1, 2000; 58(1): 77 - 87. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. Vinson, J. L. Carroll, and S. B. Pruett Mechanism of suppressed neutrophil mobilization in a mouse model for binge drinking: role of glucocorticoids Am J Physiol Regulatory Integrative Comp Physiol, October 1, 1998; 275(4): R1049 - R1057. [Abstract] [Full Text] [PDF] |
||||